The Danish Ministry of Interior and Health has announced that the political parties have decided to permanently legalize treatment with medical cannabis in Denmark. When the Danish Pilot Program expires in December 2025, the Danish Parliament will enact legislation to ensure the permanent legalization of medical cannabis treatment for patients.
This is fantastic news for Danish patients, who now have certainty that they can continue their treatment, said medical cannabis maker Stenocare, adding that it also provides a positive outlook for the Danish domestic market, where the company has been a leading supplier of prescription medical cannabis since 2018.
Minister of Interior and Health, Sophie Løhde, commented on the agreement noting: "Medical cannabis has proven to be a sought-after alternative to authorized medication for patients with serious diseases such as cancer and multiple sclerosis. Many experiences relief from pain or nausea that can significantly improve their quality of life. And with this agreement, we ensure that patients who have not had sufficient effect from other treatments will continue to be able to be prescribed medical cannabis by a doctor in a safe environment.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze